The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)

This study has been completed.
Sponsor:
Collaborators:
Procter and Gamble
Aventis Pharmaceuticals
Information provided by:
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00118508
First received: June 30, 2005
Last updated: February 8, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2006
  Primary Completion Date: July 2006 (Final data collection date for primary outcome measure)
No publications provided by University of Pittsburgh

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):